4-Isopropylcinnamaldehyde
Common Name: |
4-Isopropylcinnamaldehyde |
IUPAC Name: |
(E)-3-(4-propan-2-ylphenyl)prop-2-enal |
Molecular Formula: |
C12H22O |
SMILES: |
CC(C)C1=CC=C(C=C1)C=CC=O |
Inchi: |
1S/C12H14O/c1-10(2)12-7-5-11(6-8-12)4-3-9-13/h3-10H,1-2H3/b4-3+ |
Inchi Key: |
MHGRIUPTPRZPJP-ONEGZZNKSA-N |
Cas No: |
6975-24-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
182.30 |
Mass (g/mol) |
174.104 |
Molar Refractivity |
59.52 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
9 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
287.00 to 288.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.003 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.75 |
LogP |
3.022 |
iLOGP |
3.09 |
XLOGP3 |
4.77 |
WLOGP |
3.88 |
MLOGP |
3.16 |
ESOL Log S |
-3.38 |
ESOL Solubility (mg/ml) |
0.076 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.86 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.54 |
Silicos-IT Solubility (mg/ml) |
0.05 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.03 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.124 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.827 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |